The mechanisms whereby orofacial pain affects motor function are poorly understood. The aims were to determine (a) if lingual algesic chemical stimulation affected face MI excitability defined by intracortical microstimulation (ICMS); (b) if any such effects were limited to the motor efferent MI zones driving muscles in the vicinity of the noxious stimulus. Ketamine-anesthetized Sprague-Dawley male rats were implanted with electromyographic electrodes into anterior digastric, masseter, and genioglossus muscles. In 38 rats, 3 microelectrodes were located in left face MI at ICMS-defined sites for evoking digastric and/or genioglossus responses. ICMS thresholds for evoking electromyographic activity from each site were determined every 15 min for 1 hr then the right anterior tongue was infused (20 µl, 120 µl/hr) with glutamate (1.0 M, n=18) or isotonic saline (n=7). Subsequently, ICMS thresholds were determined every 15 min for 4 hr. In intact control rats (n=13), ICMS thresholds were recorded over 5 hr. Only left and right genioglossus ICMS thresholds were significantly increased (up to 350%) in the glutamate infusion group compared with intact and isotonic saline groups (p<0.05). These dramatic effects of glutamate on ICMS-evoked genioglossus activity contrast with its weak effects only on right genioglossus activity evoked from the internal capsule or hypoglossal nucleus. This is the first documentation that intraoral noxious stimulation results in prolonged neuroplastic changes manifested as a decrease in face MI excitability. These changes appear to occur predominantly in those parts of face MI that provide motor output to the orofacial region receiving the noxious stimulation.